FDA clears AI-powered prostate cancer detection software
pharmaphorum
SEPTEMBER 22, 2021
The software – called Paige Prostate – is the first artificial intelligence-based to be approved by the FDA for this purpose, according to the US regulator. Software that can help pathologists detect prostate cancer from slides of biopsies more effectively has been approved by the FDA. That compared to 90.9%
Let's personalize your content